The Next Healthcare Story Worth Telling May Be About Someone You Know

Résumé détaillé
AimwellBio invites patients, colleagues and healthcare organizations to nominate professionals for consideration in its 2027 editorial coverage.MIAMI, FL / ACCESS Newswire / / Inc.
AimwellBio invites patients, colleagues and healthcare organizations to nominate professionals for consideration in its 2027 editorial coverage.
MIAMI, FL / ACCESS Newswire / November 17, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, is inviting the public to nominate physicians, medical researchers, scientists and other healthcare professionals for potential features as it plans its 2027 editorial coverage.
A physician finds a better way to reach patients who struggle to access care. A researcher moves a promising line of inquiry forward. A community practitioner tackles a health need that has gone overlooked. Patients and colleagues often see the impact of this work firsthand, and AimwellBio wants to hear from them.
AimwellBio welcomes nominations from clinical medicine, biotechnology, medical research, pharmacy, rehabilitation, preventive care, healthcare technology and other areas of healthcare. Patients, colleagues, academic institutions, healthcare organizations and professional associations may submit nominations. Self-nominations are welcome.
Tell us what the person did, who their work serves and why it deserves a closer look. Where available, include links to publications, professional credentials, projects or other publicly verifiable information that helps document the contribution.
Nominations do not guarantee selection, publication, endorsement or participation in AimwellBio's professional network. Potential features are subject to review and editorial approval.
Email corporate@aimwellbio.com with the subject line Healthcare Professional Nomination. Include the professional's name, specialty, location, a short description of their contribution and, if available, a relevant public professional link. Do not include confidential patient information or private medical records.
AimwellBio, operated by Aimwell Partners Inc. (OTCID:AIMN), is a healthcare intelligence platform focused on source-traceable information, professional…
This…
Début de l'article, extrait de Yahoo Finance. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)




